ID

16658

Beschrijving

Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT00095121

Link

https://clinicaltrials.gov/show/NCT00095121

Trefwoorden

Versies (1)
  1. 30-07-16 30-07-16 -
Geüploaded op

30 juli 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Chronic Hepatitis B NCT00095121

Engels

Eligibility Chronic Hepatitis B NCT00095121

1 Formulieren  
Criteria
Beschrijving

Criteria

positive hbsag >= 6 months prior to randomization and positive hbeag at screening.
Beschrijving

Hepatitis B surface antigen positive | Hepatitis B e antigen positive

Datatype

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C0392390
serum hbv dna greater than or equal to 1 x 100,000 copies/ml (pcr assay) at initial or confirmatory screening visit.
Beschrijving

Hepatitis B DNA Measurement | Polymerase Chain Reaction

Datatype

boolean

Alias
UMLS CUI [1]
C3641250
UMLS CUI [2]
C0032520
serum alt levels greater than or equal to 1.5 x uln at both initial and confirmatory screening visits.
Beschrijving

Alanine aminotransferase measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0201836
compensated liver disease with anticipated survival greater than 12 months and with the following laboratory and clinical parameters within 4 weeks of baseline:
Beschrijving

Compensated liver disease | Continuance of life Anticipated

Datatype

boolean

Alias
UMLS CUI [1]
C3839044
UMLS CUI [2,1]
C0038952
UMLS CUI [2,2]
C3840775
*prothrombin time less than or equal to 1 second above normal range. *total bilirubin less than 1.3 mg/dl or normal direct bilirubin. *serum albumin greater than 3 g/dl (greater than 30 g/l). *no clinical history of ascites, variceal bleeding, encephalopathy or splenomegaly. *adequate renal function defined as creatinine clearance greater than or equal to 80 ml/min (calculated using schwartz formula).
Beschrijving

Prothrombin time assay | Bilirubin, total measurement | Bilirubin, direct measurement Normal | Serum albumin measurement | Ascites | Bleeding varices | Encephalopathies | Splenomegaly | Renal function | Creatinine clearance measurement Creatinine-based formula (Schwartz)

Datatype

boolean

Alias
UMLS CUI [1]
C0033707
UMLS CUI [2]
C0201913
UMLS CUI [3,1]
C0201916
UMLS CUI [3,2]
C0205307
UMLS CUI [4]
C0523465
UMLS CUI [5]
C0003962
UMLS CUI [6]
C0333106
UMLS CUI [7]
C0085584
UMLS CUI [8]
C0038002
UMLS CUI [9]
C0232804
UMLS CUI [10,1]
C0373595
UMLS CUI [10,2]
C1980037
key exclusion criteria:
Beschrijving

Exclusion Criteria Main

Datatype

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
received immunoglobulin, interferon or lamivudine therapy within 6 months prior to initial screening visit.
Beschrijving

Immunoglobulins | Interferons | Lamivudine

Datatype

boolean

Alias
UMLS CUI [1]
C0021027
UMLS CUI [2]
C0021747
UMLS CUI [3]
C0209738
participated in any investigational trial with any investigational compound within 2 months prior to initial screening.
Beschrijving

Study Subject Participation Status | Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
organ or bone marrow transplant recipients.
Beschrijving

Transplanted organ Recipient | Autologous bone marrow transplant Recipient

Datatype

boolean

Alias
UMLS CUI [1,1]
C0524930
UMLS CUI [1,2]
C1709854
UMLS CUI [2,1]
C0194037
UMLS CUI [2,2]
C1709854
clinical evidence of decompensated liver disease.
Beschrijving

Decompensated liver disease Evidence Clinical

Datatype

boolean

Alias
UMLS CUI [1,1]
C4075847
UMLS CUI [1,2]
C0332120
UMLS CUI [1,3]
C0205210
a child-pugh-turcotte score greater than 6.
Beschrijving

Child-Pugh-Turcotte score

Datatype

boolean

Alias
UMLS CUI [1]
C3854424
inability to comply with study requirements.
Beschrijving

Protocol Compliance Unable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C1299582
Terug naar het begin van de pagina

Similar models

Eligibility Chronic Hepatitis B NCT00095121

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Hepatitis B surface antigen positive | Hepatitis B e antigen positive
Item
positive hbsag >= 6 months prior to randomization and positive hbeag at screening.
boolean
C0149709 (UMLS CUI [1])
C0392390 (UMLS CUI [2])
Hepatitis B DNA Measurement | Polymerase Chain Reaction
Item
serum hbv dna greater than or equal to 1 x 100,000 copies/ml (pcr assay) at initial or confirmatory screening visit.
boolean
C3641250 (UMLS CUI [1])
C0032520 (UMLS CUI [2])
Alanine aminotransferase measurement
Item
serum alt levels greater than or equal to 1.5 x uln at both initial and confirmatory screening visits.
boolean
C0201836 (UMLS CUI [1])
Compensated liver disease | Continuance of life Anticipated
Item
compensated liver disease with anticipated survival greater than 12 months and with the following laboratory and clinical parameters within 4 weeks of baseline:
boolean
C3839044 (UMLS CUI [1])
C0038952 (UMLS CUI [2,1])
C3840775 (UMLS CUI [2,2])
Prothrombin time assay | Bilirubin, total measurement | Bilirubin, direct measurement Normal | Serum albumin measurement | Ascites | Bleeding varices | Encephalopathies | Splenomegaly | Renal function | Creatinine clearance measurement Creatinine-based formula (Schwartz)
Item
*prothrombin time less than or equal to 1 second above normal range. *total bilirubin less than 1.3 mg/dl or normal direct bilirubin. *serum albumin greater than 3 g/dl (greater than 30 g/l). *no clinical history of ascites, variceal bleeding, encephalopathy or splenomegaly. *adequate renal function defined as creatinine clearance greater than or equal to 80 ml/min (calculated using schwartz formula).
boolean
C0033707 (UMLS CUI [1])
C0201913 (UMLS CUI [2])
C0201916 (UMLS CUI [3,1])
C0205307 (UMLS CUI [3,2])
C0523465 (UMLS CUI [4])
C0003962 (UMLS CUI [5])
C0333106 (UMLS CUI [6])
C0085584 (UMLS CUI [7])
C0038002 (UMLS CUI [8])
C0232804 (UMLS CUI [9])
C0373595 (UMLS CUI [10,1])
C1980037 (UMLS CUI [10,2])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Immunoglobulins | Interferons | Lamivudine
Item
received immunoglobulin, interferon or lamivudine therapy within 6 months prior to initial screening visit.
boolean
C0021027 (UMLS CUI [1])
C0021747 (UMLS CUI [2])
C0209738 (UMLS CUI [3])
Study Subject Participation Status | Investigational New Drugs
Item
participated in any investigational trial with any investigational compound within 2 months prior to initial screening.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Transplanted organ Recipient | Autologous bone marrow transplant Recipient
Item
organ or bone marrow transplant recipients.
boolean
C0524930 (UMLS CUI [1,1])
C1709854 (UMLS CUI [1,2])
C0194037 (UMLS CUI [2,1])
C1709854 (UMLS CUI [2,2])
Decompensated liver disease Evidence Clinical
Item
clinical evidence of decompensated liver disease.
boolean
C4075847 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Child-Pugh-Turcotte score
Item
a child-pugh-turcotte score greater than 6.
boolean
C3854424 (UMLS CUI [1])
Protocol Compliance Unable
Item
inability to comply with study requirements.
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial